Cost effectiveness of option B plus for prevention of mother-to-child transmission of HIV in resource-limited countries: Evidence from Kumasi, Ghana

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  VanDeusen, Adam ^a   Paintsil, Elijah ^b   Agyarko Poku, Thomas ^c   Long, Elisa F ^d  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cost effectiveness analysis; HIV prevention; Mathematical model; Mother to child HIV transmission

Indexed keywords

ANTIVIRUS AGENT; ZIDOVUDINE; ANTIRETROVIRUS AGENT;

ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED PRACTICE; FEMALE; FERTILITY RATE; GHANA; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LIFE EXPECTANCY; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; MEDICAL RECORD REVIEW; MEDICATION COMPLIANCE; MOTHER TO CHILD TRANSMISSION; NEWBORN; OPTION B; OPTION B PLUS; OUTCOME ASSESSMENT; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PATIENT COMPLIANCE; PRENATAL CARE; QUALITY ADJUSTED LIFE YEAR; QUALITY CONTROL; QUALITY OF LIFE; RETROSPECTIVE STUDY; RISK REDUCTION; SENSITIVITY ANALYSIS; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION; YOUNG ADULT; CHEMOPROPHYLAXIS; CHILD; ECONOMICS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOTHER CHILD RELATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRESCHOOL CHILD; PREVENTION AND CONTROL; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TRANSMISSION;

ANTI-RETROVIRAL AGENTS; BREAST FEEDING; CHEMOPREVENTION; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; FEMALE; GHANA; HEALTH RESOURCES; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MODELS, ECONOMETRIC; MOTHER-CHILD RELATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; QUALITY-ADJUSTED LIFE YEARS; RETROSPECTIVE STUDIES;

EID: 84925458011     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0859-2     Document Type: Article

References (32)

1. UNAIDS. World AIDS Day Report. 2012. [ http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/JC2434_WorldAIDSday_results_en.pdf]
2. UNAIDS. Eliminating new HIV infections among children. [ http://www.unaids.org/en/targetsandcommitments/eliminatingnewhivinfectionamongchildren/]
3. WHO. Global Monitoring Framework and Strategy for the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive (EMTCT). 2012. [ http://apps.who.int/iris/bitstream/10665/75341/1/9789241504270_eng.pdf]
4. Baiden F, Baiden R, Williams J, Akweongo P, Clerk C, Debpuur C, et al. Review of antenatal-linked voluntary counseling and HIV testing in Sub-Saharan Africa: lessons and options for Ghana. Ghana Me J. 2005;39:8-13.
5. UNICEF. At a Glance: Ghana - Statistics. 2007. [ http://www.unicef.org/infobycountry/ghana_statistics.html]
6. Ghana AIDS Commission. Ghana - Country AIDS Progress Report. Reporting Period: January 2010-December 2011. UNAIDS. 2012. [ http://www.unaids.org/sites/default/files/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce:GH_Narrative_Report%5B1%5D.pdf]
7. Ghana Health Service. PMTCT annual report. Kumasi, Ghana: National AIDS/STI Control Programme, Office KR; 2011. http://www.ghanahealthservice.org/downloads/Ashanti_Region_Report_half_year_2010.pdf .
8. Shah M, Johns B, Abimiku A, Walker DG. Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited setting. AIDS. 2011;25:1093-102.
9. Ciaranello AL, Perez F, Engelsmann B, Walensky RP, Mushavi A, Rusibamayila A, et al. Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe. Clin Infect Dis. 2013;56:430-46.
10. Kuznik A, Lamorde M, Hermans S, Castelnuovo B, Auerbach B, Semeere A, et al. Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda. Bull World Health Organ. 2012;90:595-603.
11. Fasawe O, Avila C, Shaffer N, Schouten E, Chimbwandira F, Hoos D, et al. Cost-effectiveness analysis of Option B+ for HIV prevention and treatment of mothers and children in Malawi. PLoS One. 2013;8:e57778.
12. National AID, Program C. PMTCT training package for health care providers participant manual. Accra: Ghana Health Service; 2010.
13. When To Start Consortium, Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373:1352-63.
14. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. JAMA. 2001;285:1466-74.
15. Holmes CB, Wood R, Badri M, Zilber S, Wang B, Maartens G, et al. CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. JAIDS. 2006;42:464-9.
16. Deeks SG, Grant RM. Sustained CD4 responses after virological failure of protease inhibitor-containing therapy. Antivir Ther. 1999;4 Suppl 3:7-11.
17. WHO. Global Price Reporting Mechanism Report AIDS Medicines and Diagnostics Service. WHO; 2011. (http://www.who.int/hiv/amds/gprm/en/).
18. Rosen J, Asante F. Cost of HIV & AIDS adult and pediatric clinical care and treatment in Ghana. Washington, DC: Futures Group, Health Policy Initiative; 2010. http://www.healthpolicyinitiative.com/Publications/Documents/1293_1_Ghana_ART_Costing_2010_acc.pdf.
19. Tengs TO, Lin TH. A meta-analysis of utility estimates for HIV/AIDS. Med Decis Making. 2002;22:475-81.
20. UNICEF. Business leadership council. A business case for options B and B+ to eliminate mother to child transmission of HIV by 2015. 2012. http://www.unicef.org/aids/files/DISCUSSION_PAPER.A_BUSINESS_CASE_FOR_OPTIONS_B.pdf .
21. WHO. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Towards Universal Access - Recommendations for a public health approach. World Health Organization; 2010. [http://www.who.int/hiv/pub/guidelines/pmtctguidelines3.pdf]
22. UNICEF. Options B and B+: Key considerations for countries to implement an equity-focused approach. 2012. http://www.unicef.org/aids/files/hiv_Key_considerations_options_B.pdf .
23. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1253-8.
24. WHO Commission on Macroeconomics and Health. Macroeconomics and health: investing in health for economic development. Geneva: World Health Organization Commission on Macroeconomics and Health; 2001. http://whqlibdoc.who.int/publications/2001/924154550x.pdf.
25. USA Central Intelligence Agency: World Factbook - Ghana. [https://www.cia.gov/library/publications/the-world-factbook/geos/gh.html]
26. United Nations. Together We will End AIDS. Joint united nations programme on HIV/AIDS. 2012. http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/epidemiology/2012/20120725_Together_we_will_end_AIDS_en.pdf .
27. van Hulst M, Sagoe KW, Vermande JE, van der Schaaf IP, van der Tuuk Adriani WP, Torpey K, et al. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana). Value Health. 2008;11:809-19.
28. Kahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med. 2006;3:e517.
29. Long E, Stavert RR. Portfolios of biomedical HIV interventions in south Africa: a cost-effectiveness analysis. J Gen Intern Med. 2013;28(10):1294-301.
30. Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ. 2005;331:1431-7.
31. Achana FS, Debpuur C, Akweongo P, Cleland J. Postpartum abstinence and risk of HIV among young mothers in the Kassena-Nankana District of Northern Ghana. Cult Health Sex. 2010;12:569-81.
32. United Nations: The Impact of AIDS. United Nations, Department of Economic and Social Affairs PD; 2004. [http://www.un.org/esa/population/publications/AIDSimpact/1CoverNotePrefaceContents.pdf]